Moore AC - Search Results

1

Coated microneedle arrays for transcutaneous delivery of live virus vaccines.

Vrdoljak A, McGrath MG, Carey JB, Draper SJ, Hill AV, O'Mahony C, Crean AM, Moore AC. Vrdoljak A, et al. Among authors: moore ac. J Control Release. 2012 Apr 10;159(1):34-42. doi: 10.1016/j.jconrel.2011.12.026. Epub 2011 Dec 29. J Control Release. 2012. PMID: 22245683 Free PMC article.

2

A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.

Prieur E, Gilbert SC, Schneider J, Moore AC, Sheu EG, Goonetilleke N, Robson KJ, Hill AV. Prieur E, et al. Among authors: moore ac. Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):290-5. doi: 10.1073/pnas.0307158101. Epub 2003 Dec 23. Proc Natl Acad Sci U S A. 2004. PMID: 14694197 Free PMC article.

3

Splenic dendritic cell subsets prime and boost CD8 T cells and are involved in the generation of effector CD8 T cells.

Behboudi S, Moore A, Hill AV. Behboudi S, et al. Cell Immunol. 2004 Mar;228(1):15-9. doi: 10.1016/j.cellimm.2004.03.010. Cell Immunol. 2004. PMID: 15203315

4

Progress in DNA-based heterologous prime-boost immunization strategies for malaria.

Moore AC, Hill AV. Moore AC, et al. Immunol Rev. 2004 Jun;199:126-43. doi: 10.1111/j.0105-2896.2004.00138.x. Immunol Rev. 2004. PMID: 15233731 Review.

5

Dendritic cells infected by recombinant modified vaccinia virus Ankara retain immunogenicity in vivo despite in vitro dysfunction.

Behboudi S, Moore A, Gilbert SC, Nicoll CL, Hill AV. Behboudi S, et al. Vaccine. 2004 Oct 22;22(31-32):4326-31. doi: 10.1016/j.vaccine.2004.04.029. Vaccine. 2004. PMID: 15474725

6

Novel protein and poxvirus-based vaccine combinations for simultaneous induction of humoral and cell-mediated immunity.

Hutchings CL, Gilbert SC, Hill AV, Moore AC. Hutchings CL, et al. Among authors: moore ac. J Immunol. 2005 Jul 1;175(1):599-606. doi: 10.4049/jimmunol.175.1.599. J Immunol. 2005. PMID: 15972697

7

Anti-CD25 antibody enhancement of vaccine-induced immunogenicity: increased durable cellular immunity with reduced immunodominance.

Moore AC, Gallimore A, Draper SJ, Watkins KR, Gilbert SC, Hill AV. Moore AC, et al. J Immunol. 2005 Dec 1;175(11):7264-73. doi: 10.4049/jimmunol.175.11.7264. J Immunol. 2005. PMID: 16301631

8

Safety of recombinant fowlpox strain FP9 and modified vaccinia virus Ankara vaccines against liver-stage P. falciparum malaria in non-immune volunteers.

Webster DP, Dunachie S, McConkey S, Poulton I, Moore AC, Walther M, Laidlaw SM, Peto T, Skinner MA, Gilbert SC, Hill AV. Webster DP, et al. Among authors: moore ac. Vaccine. 2006 Apr 5;24(15):3026-34. doi: 10.1016/j.vaccine.2005.10.058. Epub 2006 Feb 2. Vaccine. 2006. PMID: 16488059 Clinical Trial.

9

Safety, immunogenicity, and efficacy of prime-boost immunization with recombinant poxvirus FP9 and modified vaccinia virus Ankara encoding the full-length Plasmodium falciparum circumsporozoite protein.

Walther M, Thompson FM, Dunachie S, Keating S, Todryk S, Berthoud T, Andrews L, Andersen RF, Moore A, Gilbert SC, Poulton I, Dubovsky F, Tierney E, Correa S, Huntcooke A, Butcher G, Williams J, Sinden RE, Hill AV. Walther M, et al. Infect Immun. 2006 May;74(5):2706-16. doi: 10.1128/IAI.74.5.2706-2716.2006. Infect Immun. 2006. PMID: 16622207 Free PMC article.

10

Combination of protein and viral vaccines induces potent cellular and humoral immune responses and enhanced protection from murine malaria challenge.

Hutchings CL, Birkett AJ, Moore AC, Hill AV. Hutchings CL, et al. Among authors: moore ac. Infect Immun. 2007 Dec;75(12):5819-26. doi: 10.1128/IAI.00828-07. Epub 2007 Oct 1. Infect Immun. 2007. PMID: 17908809 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters